The Future of Healthcare: “There is a need for prioritization of researching disease states that still have little-to-no treatment options” with Maurice R. Ferré, MD of INSIGHTEC

There is a need for increased funding and prioritization of researching disease states that still have little-to-no treatment options. Neurology is a particular challenge, especially with the growing aging population. For instance, according to Alzheimer’s Disease International, someone develops dementia every three seconds and the current annual cost of dementia is estimated at US $1 trillion, a figure set to double by 2030.

As a part of my interview series with leaders in healthcare, I had the pleasure to interview Maurice R. Ferré, MD. Maurice is the CEO and Chairman of the Board of Directors at INSIGHTEC, the innovator of incisionless surgery using focused ultrasound. Dr. Ferré brings over 20 years of experience as a serial entrepreneur in the medical technology industry. He was the recipient of the prestigious Ernest & Young 2007 Entrepreneur of the Year Award…